Sinclair keeps pumping out interviews. Here’s a really long one with some bits I found interesting:
"A few years later, the company he’d founded, Sirtris Pharmaceuticals, was bought for US$720 million by GlaxoSmithKline (his less than 1 per cent ownership stake still netted him a tidy sum)."
- So he got less than $7 million before tax from that.
"Sinclair is aiming to get his own NAD+-boosting tablets on the market within three years. Unlike the other companies, he’s taking his research through the US FDA’s arduous drug-approval process so that, if clinical trials are successful, it can be sold not as a supplement but as a pharmaceutical drug, and prescribed by doctors. Since the FDA won’t approve drugs for treating old age, one of his companies, MetroBiotech, will market the boosters to treat rare diseases, and another, JumpStart Fertility, will sell them to reverse female infertility. The NAD+ booster furthest along in this process is called MIB-626; second-phase human trials are underway."
- I'm not totally sure, but believe MIB-626 is the NMN H2so4 combo that they used in the mouse study published in march
Edited by able, 10 September 2018 - 07:54 PM.